Skip to main content
Log in

Oestrogen receptor (ESR) polymorphisms and breast cancer susceptibility

  • Original Investigation
  • Published:
Human Genetics Aims and scope Submit manuscript

Abstract

The allele frequencies of three restriction fragment length polymorphisms at the oestrogen receptor (ESR) locus were compared between breast cancer patients and controls. Leucocyte or tumour DMA from 238 and 122 patients, respectively, and leucocyte DNA from 672 controls was analysed. Alleles having the XbaI restriction site detected by the M72 probe (covering exon 2 and flanking introns) were significantly more frequent in patients than in controls (P = 0.033). Within the breast cancer population, the presence of the XbaI restriction site was associated with late onset of the disease but this association was only of borderline significance. The allele frequencies of the BstUI polymorphism in exon 1 and the PvuII polymorphism in intron 1 did not differ between cases and controls. However, alleles with the PvuII restriction site were more frequent in patients with progesterone receptor negative primary tumours than in patients with progesterone receptor positive primary tumours (P = 0.027). There was no significant association between any of the ESR polymorphisms and the oestrogen receptor status of the primary tumours. The results indicate that the ESR gene or a gene closely linked to it is involved in the development of at least a subset of breast carcinomas.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  • Beahrs OH, Henson DE, Hutter RVP, Myers MH (1988) Manual for staging of cancer, 3rd edn. Lippincott, Philadelphia, p 145

    Google Scholar 

  • Bodmer WF (1984) HLA system. In: Albert ED, Baur MP, Mayr WR (eds) Histocompatibility testing. Springer, Berlin Heidelberg New York, pp 11–22

    Google Scholar 

  • Birch JM, Hartley AL, Tricker KJ, Prosser J, Condie A, Kelsey AM, Harris M, Morris Jones PH, Binchy A, Crowther D, Craft AW, Eden OB, Evans GR, Thompson E, Mann JR, Martin J, Mitchell ELD, Santibanez-Kortef MF (1994) Prevalence and diversity of constitutional mutations in the p53 gene among 21 Li-Fraumeni families. Cancer Res 54: 1298–1304

    Google Scholar 

  • Børresen A-L, Anderson TI, Garber J, Barbier-Piraux N, Thorlacius S, Eyfjörd J, Ottestad L, Smith-Sørensen, Hovig E, Malkin D, Friend SH (1992) Screening for germ-line TP53 mutations in breast cancer patients. Cancer Res 52: 3234–3236

    Google Scholar 

  • Castagnoli A, Maestri I, Bernardi F, Del Senno L (1987) PvuII RFLP inside the human estrogen receptor gene. Nucleic Acids Res 15: 866

    Google Scholar 

  • Clerget Darpoux F, Bonaïti-Pellié C (1992) Strategies based on marker information for the study of human disease. Ann Hum Genet 56: 147–155

    Google Scholar 

  • Devilee P, Voesten A, Van Vliet M, Kuipers-Dijkshoorn N, Trent JM, Cornelisse CJ (1991) The common region for loss of heterozygosity on chromosome 6q in a series of breast tumours maps between the markers D6S37 and SOD2. Cytogenet Cell Genet 58: 1909

    Google Scholar 

  • Easton DF, Bishop DT, Ford D, Crockford GP (1993) Genetic linkage analysis in familial breast and ovarian cancer — results from 214 families. Am J Hum Genet 52: 678–701

    Google Scholar 

  • Feinberg AP, Vogelstein B (1983) A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity. Anal Biochem 132: 6–13

    CAS  PubMed  Google Scholar 

  • Garcia T, Lehrer S, Bloomer WD, Schachter B (1988) A variant estrogen receptor messenger ribonucleic acid is associated with reduced levels of estrogen binding in human mammary tumors. Mol Endocrinol 2: 785–791

    CAS  PubMed  Google Scholar 

  • Green S, Chambon P (1987) Oestradiol induction of a glucocorticoid-responsive gene by a chimeric receptor. Nature 325: 75–78

    Google Scholar 

  • Greenberg DA (1993) Linkage analysis of “necessary” disease loci versus “susceptibility” loci. Am J Hum Genet 52: 135–143

    Google Scholar 

  • Hall JM, Lee MK, Newman B, Morrow JE, Anderson LA, King M-C (1990) Linkage of early-onset familial breast cancer to chromosome 17q21. Science 250: 1684–1689

    Google Scholar 

  • Hall JM, Friedman L, Guenther C, Lee MK, Weber JM, Black DM, King M-C (1992) Closing in on the breast cancer gene on chromosome 17q. Am J Hum Genet 50: 1235–1242

    Google Scholar 

  • Hill SM, Fuqua SAW, Chamness GC, Greene GL, McGuire WL (1989) Estrogen receptor expression in human breast cancer associated with an estrogen receptor gene restriction fragment polymorphism. Cancer Res 49: 145–148

    Google Scholar 

  • Kumar V, Green S, Staub A, Chambon P (1986) Localization of the oestradiol-binding and putative DNA-binding domains of the human oestrogen receptor. EMBO J 5: 2231–2236

    Google Scholar 

  • Kunkel LM, Smith, KD, Boyer SH, Borgaonkar DS, Wachtel SS, Miller OJ, Breg WR, Jones HW Jr, Rary JM (1977) Analysis of human Y-chromosome-specific reiterated DNA in chromosome variants. Proc Natl Acad Sci USA 74: 1245–1249

    CAS  PubMed  Google Scholar 

  • Lehrer S, Sanchez M, Song HK, Dalton J, Levine E, Savoretti P, Thung SN, Schachter B (1990) Oestrogen receptor B-region polymorphism and spontaneous abortion in women with breast cancer. Lancet 335: 622–624

    Google Scholar 

  • Lehrer S, Levine E, Savoretti P, Cropley J, Thung SN, Song HK, Mandell L, Shank B (1992) Oestrogen and progesterone receptor dissociation and family history of breast cancer. Lancet 339: 1108–1109

    Google Scholar 

  • Li FP, Fraumeni Jr JF, Mulvihill JJ, Blattner WA, Dreyfus MG, Tucker MA, Miller RW (1988) A cancer family syndrome in twenty-four kindreds. Cancer Res 48: 5358–5362

    CAS  PubMed  Google Scholar 

  • Lobaccaro J-M, Lumbroso S, Belon C, Galtier-Dereure F, Bringer J, Lesimple T, Heron J-F, Pujol H, Sultan C (1993) Male breast cancer and the androgen receptor gene. Nature Genet 5: 109–110

    Google Scholar 

  • Lynch HT, Albano WA, Danes S, Layton MA, Kimberling WJ, Lynch JF, Cheng SC, Costello KA, Mulcahy GM, Wagner CA, Tindall SL (1984) Genetic predisposition to breast cancer. Cancer 53: 612–622

    Google Scholar 

  • Lynch HT, Watson P, Conway T, Fitzsimmons SL, Lynch J (1988) Breast cancer family history as a risk factor for early onset breast cancer. Breast Cancer Res Treat 11: 263–267

    Google Scholar 

  • Malkin D, Li FP, Strong LC, Fraumeni JF Jr, Nelson CE, Kim DH, Kassel J, Gryka MA, Bischoff FZ, Tainsky MA, Friend SH (1990) Germ line p53 mutations in a familial syndrome of breast cancer, sarcomas, and other neoplasms. Science 250: 1233–1238

    Google Scholar 

  • May FEB, Johnson MD, Wisseman LR, Wakeling AE, Kasatner P, Westley BR (1989) Regulation of progesterone receptor mRNA by oestradiol and antioestrogen in breast cancer cell lines. J Steroid Biochem 33: 1035–1041

    Google Scholar 

  • Menasce LP, White GRM, Harrison CJ, Boyle JM (1993) Localization of the estrogen receptor locus (ESR) to chromosome 6q25. 1 by FISH and a simple post-FISH banding technique. Genomics 17: 263–265

    Google Scholar 

  • Narod S, Feunteun J, Lynch HT, Watson P, Conway T, Lynch J, Lenoir G (1991) Familial breast-ovarian cancer locus on chromosome 17ql2-q23. Lancet 338: 82–83

    Google Scholar 

  • Parl FF, Cavener DR, Dupont WD (1989) Genomic DNA analysis of the estrogen receptor gene in breast cancer. Breast Cancer Res Treat 14: 57–64

    Google Scholar 

  • Ponglikitmongkol M, Green S, Chambon P (1988) Genomic organization of the human oestrogen receptor gene. EMBO J 7: 3385–3388

    Google Scholar 

  • Prosser J, Porter D, Coles C, Condie A, Thompson AM, Chetty U, Steel CM, Evans HJ (1992) Constitutional p53 mutation in a non-Li-Fraumeni cancer family. Br J Cancer 65: 527–528

    Google Scholar 

  • Schmutzler RK, Sanchez M, Lehrer S, Chaparro CA, Phillips C, Rabin J, Sehachter B (1991) Incidence of an estrogen receptor polymorphism in breast cancer patients. Breast Cancer Res Treat 19: 111–117

    Google Scholar 

  • Sideransky D, Tokino T, Helzisouer K, Rausch G, Zehnbauer B, Shelton B, Prestiglacomo L, Vogelstein B, Davidson N (1992) Inherited p53 gene mutations in breast cancer. Cancer Res 52: 2984–2986

    Google Scholar 

  • Schachter B, Harlap S, Chaparro A, Rabin J, Lehrer S (1994) Estrogen receptor gene variant, spontaneous abortion and breast cancer risk. Proc Am Assoc Cancer Res 35: 290

    Google Scholar 

  • Southern EM (1975) Detection of specific sequences among DNA fragments separated by gel electrophoresis. J Mol Biol 98: 503–517

    CAS  PubMed  Google Scholar 

  • Srivastava S, Zou Z, Pirollo K, Blattner W, Chang EH (1990) Germ line transmission of a mutated p53 gene in a cancer-prone family with Li-Fraumeni syndrome. Nature 348: 747–749

    Google Scholar 

  • Taylor JA, Li Y, You M, Wilcox AJ, Liu E (1992) B region variant of the estrogen receptor gene. Nucleic Acids Res 20: 2895

    Google Scholar 

  • Vollenweider-Zerargui L, Barrelet L, Wong Y, Lemarchand-Béraud T, Gómez F (1986) The predictive value of estrogen and progesterone receptors' concentrations on the clinical behavior of breast cancer in women. Cancer 57: 1171–1180

    Google Scholar 

  • Winstanley J, Cooke T, George WD, Murray G, Holt S, Cronton R, Griffiths K, Nicholson R (1991) The long term prognostic signficance of oestrogen receptor analysis in early carcinoma of the breast. Br J Cancer 64: 99–101

    Google Scholar 

  • Wooster R, Mangion J, Eeles R, Smith S, Dowsett M, Averill D, Barrett-Lee P, Easton DF, Ponder BAJ, Stratton MR (1992) A germeline mutation in the androgen receptor gene in two brothers with breast cancer and Reifenstein syndrome. Nature Genet 2: 132–134

    Google Scholar 

  • Yaich L, Dupont WD, Cavener DR, Parl FF (1992) Analysis of the PvuII restriction fragment-length polymorphism and exon structure of the estrogen receptor gene in breast cancer and peripheral blood. Cancer Res 52: 77–83

    Google Scholar 

  • Zuppan PJ, Hall JM, Ponglikitmongkol M, Spielman R, King M-C (1989) Polymorphisms at the estrogen receptor (ESR) locus and linkage relationships on chromosome 6q. Cytogenet Cell Genet 51: 1116

    Google Scholar 

  • Zuppan P, Hall JM, Lee MK, Ponglikitmongkol M, King M-C (1991) Possible linkage of the estrogen receptor gene to breast cancer in a family with late-onset disease. Am J Hum Genet 48: 1065–1068

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Anderson, T.I., Heimdal, K.R., Skrede, M. et al. Oestrogen receptor (ESR) polymorphisms and breast cancer susceptibility. Hum Genet 94, 665–670 (1994). https://doi.org/10.1007/BF00206961

Download citation

  • Received:

  • Revised:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00206961

Keywords

Navigation